Home LiteratureArticle Details
PMID: 16177364 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae.

Infection and immunity ·Vol. 73 ·No. 10 ·2005-10-00 ·Pages 6852-9

Jomaa M, Yuste J, Paton JC, Jones C, Dougan G, Brown JS

Abstract

PiaA and PiuA are the lipoprotein components of the Pia and Piu Streptococcus pneumoniae iron uptake ABC transporters and are required for full virulence in mouse models of infection. Active or passive vaccination with recombinant PiuA and PiaA protects mice against invasive S. pneumoniae disease. In this study we have analyzed the antibody responses and mechanism of protection induced by PiuA and PiaA in more detail. For both proteins, two booster vaccinations induced stronger antibody responses in mice than a single or no booster vaccinations, and 5 mug of protein induced similar levels of antibody responses as 20 mug. Immunoglobulin G (IgG) subclass-specific enzyme-linked immunosorbent assays demonstrated that the antibody response to PiuA and PiaA was predominantly IgG1, with induction of only low levels of IgG2a. Anti-PiaA and anti-PiuA polyclonal rabbit antibodies bound to the surface of live S. pneumoniae when assessed by flow cytometry but did not inhibit growth of S. pneumoniae in cation-depleted medium or bacterial susceptibility to the iron-dependent antibiotic streptonigrin. However, anti-PiaA and anti-PiuA did increase complement-independent and -dependent opsonophagocytosis of different serotypes of S. pneumoniae by the human neutrophil cell line HL60. Hence, vaccination with PiaA and PiuA protects against S. pneumoniae infection by inducing antibodies that promote bacterial opsonophagocytosis rather than inhibiting iron transport.

MeSH Terms
ATP-Binding Cassette Transporters/immunology Animals Antibodies, Bacterial/blood,immunology,pharmacology Bacterial Proteins/immunology Biological Transport/drug effects HL-60 Cells Humans Immunoglobulin G/blood Iron/metabolism Lipoproteins/immunology Mice Phagocytosis Pneumococcal Infections/immunology,prevention & control Rabbits Streptococcal Vaccines Streptococcus pneumoniae/immunology
Chemicals
ATP-Binding Cassette Transporters Antibodies, Bacterial Bacterial Proteins Immunoglobulin G Lipoproteins Streptococcal Vaccines Iron
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Jomaa Maha
Centre for Biological Sciences, Imperial College London, UK.
Yuste Jose
Paton James C
Jones Christopher
Dougan Gordon
Brown Jeremy S
References (29)
29 references, click to expand
  1. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection.
    Infect Immun. 2001 Nov;69(11):6702-6 PMID: 11598041
  2. Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.
    Infect Immun. 2001 Oct;69(10):5997-6003 PMID: 11553536
  3. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.
    Vaccine. 2001 Dec 12;20(5-6):805-12 PMID: 11738744
  4. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Infect Immun. 2005 Mar;73(3):1304-12 PMID: 15731027
  5. Characterization of pit, a Streptococcus pneumoniae iron uptake ABC transporter.
    Infect Immun. 2002 Aug;70(8):4389-98 PMID: 12117949
  6. Iron acquisition by Gram-positive bacterial pathogens.
    Microbes Infect. 2002 Sep;4(11):1149-56 PMID: 12361915
  7. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.
    Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16969-74 PMID: 12477926
  8. A solute binding protein of Streptococcus pneumoniae iron transport.
    FEMS Microbiol Lett. 2003 Mar 28;220(2):303-8 PMID: 12670696
  9. Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: contribution of both humoral and cellular immune responses.
    FEMS Immunol Med Microbiol. 2003 Jun 10;37(1):53-7 PMID: 12770760
  10. Novel vaccine strategies with protein antigens of Streptococcus pneumoniae.
    FEMS Immunol Med Microbiol. 2003 Aug 18;38(1):1-7 PMID: 12900048
  11. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
    N Engl J Med. 2003 Oct 2;349(14):1341-8 PMID: 14523142
  12. FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis.
    J Exp Med. 2004 Mar 1;199(5):717-23 PMID: 14981111
  13. CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.
    Infect Immun. 2004 May;72(5):2689-97 PMID: 15102777
  14. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants.
    Pediatr Infect Dis. 1986 Jan-Feb;5(1):45-50 PMID: 3945575
  15. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type.
    Infect Immun. 1991 Jan;59(1):222-8 PMID: 1987036
  16. Lipoproteins of gram-positive bacteria.
    J Bacteriol. 1995 Mar;177(5):1123-8 PMID: 7868582
  17. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.
    Infect Immun. 1997 Feb;65(2):640-4 PMID: 9009325
  18. A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine.
    Clin Diagn Lab Immunol. 1999 Jul;6(4):581-6 PMID: 10391867
  19. PiuA and PiaA, iron uptake lipoproteins of Streptococcus pneumoniae, elicit serotype independent antibody responses following human pneumococcal septicaemia.
    FEMS Immunol Med Microbiol. 2005 Jan 1;43(1):73-80 PMID: 15607639
  20. Bacteremia among children admitted to a rural hospital in Kenya.
    N Engl J Med. 2005 Jan 6;352(1):39-47 PMID: 15635111
  21. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.
    Pediatr Infect Dis J. 2000 Mar;19(3):187-95 PMID: 10749457
  22. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.
    Infect Immun. 2000 May;68(5):3028-33 PMID: 10769009
  23. Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections.
    Infect Immun. 2000 Jun;68(6):3200-9 PMID: 10816464
  24. The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses.
    Infect Immun. 2000 Jul;68(7):4180-8 PMID: 10858235
  25. Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
    N Engl J Med. 2001 Feb 8;344(6):403-9 PMID: 11172176
  26. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection.
    Infect Immun. 2001 Mar;69(3):1593-8 PMID: 11179332
  27. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines.
    Thorax. 2001 Apr;56(4):296-301 PMID: 11254821
  28. A Streptococcus pneumoniae pathogenicity island encoding an ABC transporter involved in iron uptake and virulence.
    Mol Microbiol. 2001 May;40(3):572-85 PMID: 11359564
  29. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.
    Infect Immun. 2001 Nov;69(11):6718-24 PMID: 11598043
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2005-10-00
Pages
6852-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC1230898
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com